Glioblastoma Vaccine Hits Primary Endpoints in Phase 1
This phase 1 trial did better than expected (but that is only with the endpoint of safety and immune response, they did not mention survival in the article). Sounds like a great concept. They have an approach similiar to ICT-107 but with different targets. We will be keeping an eye on this one!
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://www.dddmag.com/news/2014/04/glioblastoma-vaccine-hits-primary-endpoints-phase-1
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines